CooperCompanies announced that the Company’s Board of Directors has appointed Walter Rosebrough, Jr. as an independent director, effective as of January 3, 2026. In connection with this appointment, the Company also has entered into a cooperation agreement with Browning West. Rosebrough will join the Board’s Corporate Governance & Nominating Committee. The Board has also agreed that, by the end of 2026, it shall provide due and serious consideration for Rosebrough to be appointed Chair of the Board. In addition, the Board will identify and appoint a new independent director with medical technology experience, with the mutual agreement of Browning West.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COO:
- Early notable gainers among liquid option names on December 17th
- Cooper Companies CEO buys $808K in common stock
- Cooper Companies price target raised to $71 from $64 at Goldman Sachs
- Cooper Companies price target raised to $88 from $72 at Citi
- Cooper Companies price target raised to $91 from $85 at Barclays